AZN/BMY acquisition of Amylin – A step towards leadership in diabetes space
![](/report_cover/5562/aznbmy_acquisition_of_amylin_a_step_towards_leadership_in_diabetes_space_en.gif)
Amylin, Acquisition, BMY, AZN, Bydureon, Byetta, GLP-1 agonists, Type 2 Diabetes, Dulaglutide
COMPANIES MENTIONED
Bristole -Myers, Astrazeneca, Amylin
Bristole -Myers, Astrazeneca, Amylin